IBBQ

Invesco Nasdaq Biotechnology ETF · NAS

Category Health Care
Expense Ratio 0.19%
Listing Date Jun 11, 2021
Volume 8,484.0
Market Cap (AUM) $41.32M

Performance

-1.14%

-1.79%

+0.35%

-8.92%

+3.23%

YTD

+2.82%

Top Holdings

Name
Symbol
%Assets
Amgen Inc.AMGN9.17%
Vertex Pharmaceuticals IncorporatedVRTX9.08%
Regeneron Pharmaceuticals, Inc.REGN8.77%
Gilead Sciences, Inc.GILD7.70%
Moderna, Inc.MRNA5.31%
Astrazeneca PLC Sponsored ADRAZN4.73%
Biogen Inc.BIIB3.40%
Alnylam Pharmaceuticals, IncALNY2.05%
Illumina, Inc.ILMN1.78%
BioMarin Pharmaceutical Inc.BMRN1.65%

Advanced Technical Analysis

Technical Analysis of IBBQ 2025-03-14

The stock indicators reflect a bearish sentiment overall, with a Moving Average Score of 0 indicating strong downward pressure, while the Oscillators Score of 45 suggests a neutral stance, and the Technical Score of 22 reinforces the bearish outlook. This combination implies that the stock is currently facing significant challenges, with limited...

Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

Recent News & Updates

2022-01-19 08:38
Apexium Financial, LP Buys Fidelity MSCI Health Care Index ETF, Fidelity MSCI Information ...(Yahoo Finance)
2021-06-16 18:00
By next summer we'll have enough vaccines to vaccinate the world: Eli Lilly CEO(Yahoo Finance)
2021-06-16 18:00
Influencers with Andy Serwer: David Ricks(Yahoo Finance)
2021-06-15 21:57
FDA shifting the bar for approval with new Alzheimers drug: Eli Lilly CEO(Yahoo Finance)
2021-06-10 21:00
Invesco Expands Longstanding Partnership with Nasdaq with Two New Thematic Technology ETFs(Yahoo Finance)

Page 1 of 1

previousnext

Disclaimer: The information provided here and on kavout.com is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout makes no recommendations regarding investment decisions based on this information. You are solely responsible for your investments. Please conduct your own research and consult qualified financial advisors before investing. Past performance does not guarantee future results.